Publications by authors named "Donna Graham"

Claim this Profile
U
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendations.
Paul O'Regan, Fouziah Butt, Louise Carter, Donna M Graham, Anja Le Blanc

Front Digit Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Clinician Perspectives on the Communication of Genomic Results in Cancer Care.
Eleanor Johnston, Zoulikha Zair, Leanna Goodwin, Louise Carter, Fiona Thistlethwaite, Donna M Graham

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs.
Oskar Wysocki, Sammie Mak, Hannah Frost, Donna M Graham, Dónal Landers

Int J Med Inform· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.
Sammy Shaya, Okezie Uche-Ikonne, Bedirhan Kilerci, Julie Stevenson, Alastair Greystoke, Donna M Graham

J Immunother Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients.
Julio Herrero Colomina, Eleanor Johnston, Kate Duffus, Zoulikha M Zaïr, Fiona Thistlethwaite, Donna Graham

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single centre experience of patients with rare cancers referred for early phase clinical trials.
Angelos Angelakas, Natalie Cook, Donna M Graham, Matthew Krebs, Fiona Thistlethwaite

BMC Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, Donna M Graham

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study.
Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, Eduardo Yanez, Seock-Ah Im, Donna M Graham

Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: analysis of a UK-based population.
Tom Waddell, Manon Pillai, Kate Armitage, Donna M Graham, Michael Moran

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.
Jenna H Rannikko, Loic Verlingue, Maria de Miguel, Annika Pasanen, Debbie Robbrecht, Donna M Graham

Cell Rep Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.
Paul O'Regan, Richard Hoskins, Christopher Grave, Julie-Anne Stevenson, Hannah Frost, Donna M Graham

JCO Clin Cancer Inform· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient attrition in Molecular Tumour Boards: a systematic review.
Hannah Frost, Donna M Graham, Louise Carter, Paul O'Regan, Dónal Landers

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
Patricio Serra-Bellver, Judith M Versluis, Honey K Oberoi, Cong Zhou, Timothy D Slattery, Donna M Graham

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.
Oskar Wysocki, Cong Zhou, Jacobo Rogado, Prerana Huddar, Rohan Shotton, Donna M Graham

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.
Rebecca J Lee, Oskar Wysocki, Cong Zhou, Rohan Shotton, Ann Tivey, Donna M Graham

JCO Clin Cancer Inform· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology patients' experiences in experimental medicine cancer trials: a qualitative study.
Chelsea Sawyer, Laurie Preston, Sally Taylor, Michelle Davies, Louise Carter, Donna Graham

BMJ Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrolment of older adults with cancer in early phase clinical trials-an observational study on the experience in the north west of England.
Fabio Gomes, Tine Descamps, Jessica Lowe, Martin Little, Rosie Lauste, Donna Graham

Age Ageing· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials.
Bethany Geary, Erin Peat, Sarah Dransfield, Natalie Cook, Fiona Thistlethwaite, Donna Graham

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors.
Nadina Tinsley, Donna M Graham, Natalie Cook

Ann Transl Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.
Nadina Tinsley, Cong Zhou, Grace Tan, Samuel Rack, Paul Lorigan, Donna Graham

Oncologist· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latency and interval therapy affect the evolution in metastatic colorectal cancer.
Hamid Nikbakht, Selin Jessa, Mahadeo A Sukhai, Madeleine Arseneault, Tong Zhang, Donna M Graham

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Donna Graham

Nat Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of HPV-associated oropharyngeal cancer-Authors' reply.
Donna Graham, Gillian Prue, Peter Baker, Chris Nutting, Peter Greenhouse

Lancet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It is time for universal HPV vaccination.
Gilliam Prue, Peter Baker, Donna Graham, Chris Nutting, Peter Greenhouse

Lancet· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
Kerry Lynn Reynolds, Philippe L Bedard, Se-Hoon Lee, Chia-Chi Lin, Josep Tabernero, Donna M Graham

BMC Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis